Company Monitoring Page for Novartis

latest headlines for company on cafepharma

Novartis sales down -2% but ahead of estimates in Q2
Drug Delivery Business News
Tue, 07/18/17 - 10:46 pm
Tags:
Novartis, earnings
Novartis unit Alcon posts modest Q2 gain
Mass Device
Tue, 07/18/17 - 09:49 am
Tags:
Novartis, Alcon, eye health, earnings, devices
Pfizer Is Set to Lose Its No. 1 Spot Among Drugmakers: Here's Why It Doesn't Matter
Motley Fool
Sun, 07/16/17 - 03:49 pm
Tags:
Novartis, Pfizer
How Novartis' FDA Win In Cancer Also Could Be A Boon For Its Rivals
Investors Business Daily
Fri, 07/14/17 - 08:07 am
Tags:
Novartis, CAR-T, CTL019, Kite Pharma, Bluebird Bio
Novartis stocks drug cabinet with "Big-3" arthritis blockbusters
Yahoo/Reuters
Fri, 07/14/17 - 07:58 am
Tags:
Novartis, rheumatoid arthritis, generics, Sandoz, Amgen, Enbrel, JNJ, Remicade, AbbVie, Humira
Novartis wins unanimous support from FDA panel on groundbreaking CAR-T med
Fierce Pharma
Wed, 07/12/17 - 04:29 pm
Tags:
Novartis, CAR-T, FDA, advisory panels, CTL019
D-day: Novartis arrives at a crossroad in the blockbuster race to win the first FDA OK for CAR-T
Endpoints
Wed, 07/12/17 - 11:00 am
Tags:
Novartis, FDA, CAR-T, CTL019
Lilly revs up to challenge Pfizer, Novartis in breast cancer with abemaciclib 'priority' nod
Fierce Pharma
Tue, 07/11/17 - 09:56 am
Tags:
Eli Lilly, Pfizer, Novartis, breast cancer, abemaciclib, Ibrance, Kisqali
Novartis hits pause on Fovista agreement
BioPharma Dive
Mon, 07/10/17 - 11:21 pm
Tags:
Novartis, Fovista, Ophthotech, wet age-related macular degeneration
FDA panel to focus on safety of Novartis gene therapy drug
Yahoo/Reuters
Mon, 07/10/17 - 09:32 am
Tags:
FDA, advisory panels, Novartis, gene therapy, CAR-T, acute lymphoblastic leukemia
Prescribed Reading: I/O is the only game in town
BioPharma Dive
Sat, 07/8/17 - 10:02 am
Tags:
immuno-oncology, Celgene, BeiGene, Endo International, Opana ER, Novartis, Orkambi, Vertex Pharmaceuticals, Merck, Bristol-Myers Squibb, Roche, Opdivo, Keytruda, Orencia
Novartis turns to Oxford BioMedica for a major CAR-T supply deal
Endpoints
Thu, 07/6/17 - 02:35 pm
Tags:
Novartis, Oxford BioMedica, CAR-T, CTL019
Industry paid $8.2B to docs, hospitals last year
BioPharma Dive
Wed, 07/5/17 - 07:27 pm
Tags:
physicians, physician payments, Roche, Novartis, Pfizer
Biogen aims to block Tecfidera generics with flurry of lawsuits
Bizjournals.com
Tue, 07/4/17 - 11:22 pm
Tags:
Biogen, Tecfidera, generics, MS, multiple sclerosis, Novartis, Sandoz, Mylan Labs
Details on surprise Novartis heart drug success due Aug 27
Yahoo/Reuters
Thu, 06/29/17 - 09:45 am
Tags:
Novartis, canakinumab, heart attacks, stroke
Novartis scores second biosimilar approval in two weeks
BioPharma Dive
Thu, 06/29/17 - 09:43 am
Tags:
Novartis, biosimilars, Enbrel, Europe, Sandoz, Erelzi, Roche, Rituxan
[video]Will AbbVie Outsmart Biosimilars, and Can Clovis Win the PARP Race?
Motley Fool
Tue, 06/27/17 - 09:45 am
Tags:
AbbVie, biosimilars, Humira, Clovis Oncology, Rubraca, Novartis, Regeneron, Eylea
Little Alder bags positive PhIII migraine data, but giant rivals are racing ahead in a crowded field
Endpoints
Tue, 06/27/17 - 09:38 am
Tags:
Alder Biopharma, migraines, clinical trials, eptinezumab, Eli Lilly, Amgen, Novartis, Merck
EMA Recommends New HCV, Cancer and MS Drugs for Approval
RAPS.org
Sat, 06/24/17 - 09:11 am
Tags:
Europe, EMA, hepatitis C, multiple sclerosis, breast cancer, renal cell carcinoma, AbbVie, Maviret, Gilead Sciences, Vosevi, Biogen, Amgen, Samsung Bioepis, biosimilars, Humira, Novartis, Kisqali, EUSA, Fotivda
Novartis picks up FDA approval for targeted lung cancer meds Tafinlar, Mekinist
Fierce Pharma
Fri, 06/23/17 - 03:35 pm
Tags:
Novartis, FDA, Tafinlar, Mekinist, non-small cell lung cancer, BRAF V600

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.